Qlucore AB (publ) offers visualization-based bioinformatics data analysis tools for research and precision diagnostics in Sweden and internationally. The company offers Qlucore Omics Explorer, a bioinformatics software for research in life science, biotech, food, and plant industries, as well as academia; Qlucore Insights, a software for clinical data analysis; and Qlucore Diagnostics, a CE-marked IVDR software which offers RNA-seq based cancer diagnostics. Qlucore AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.…
Qlucore (STO: QCORE) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Software - Application industry, part of the Technology sector, and reports about 12 employees.
The shares were at 0.2800 SEK on 19 November 2026, down 40.9% over 52 weeks. Its 52-week range is 0.2130 SEK to 0.5800 SEK: the price is 51.7% below the high and 31.5% above the low.
Its market capitalisation is 12.01M SEK.
Qlucore reports return on equity of -100.6%, an operating margin of -290.1% and revenue up 109.9% year over year.
It holds more cash than debt, a net cash position of 4.81M SEK. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.
No upcoming events tracked.